ISPOR—The Professional Society for Health Economics and Outcomes Research

News Release: ISPOR—The Professional Society for Health Economics and Outcomes Research announces its 2025-2026 Board of Directors. Dr Uwe Siebert will assume the role of president after having served as president-elect for the past year. Dr Eberechukwu Onukwugha will move into the position of immediate past president. Dr Beth Devine was recently elected as president-elect. The 2025-2026 board will assume office on July 1. Welcome to the entire Board. #HEOR #healthcare https://ow.ly/uwaA50VK1LB

The recent International Reference Pricing (IRP) Executive Order from the White House in the Unites States is a significant policy shift that will have far-reaching implications for health and healthcare decision making in the US and globally. At ISPOR—The Professional Society for Health Economics and Outcomes Research (HEOR), we are assessing national and global impacts of such a policy shift. We believe that all health and healthcare decisions – including pricing decisions – must be guided by transparent, rigorous, scientifically grounded methodologies that reflect the complex nuances of local health systems, social, cultural and economic contexts, and patient-centered values.  To this end, ISPOR supports any effort to integrate scientific evidence into pricing decisions, as that best serves patients.  Stay tuned for more from ISPOR as we continue to engage on this topic and advocate for evidence-driven policy solutions.

In Adair et al’s #SystematicReview of existing cost-effectiveness modeling methods for #ColorectalCancer screening from a modeler’s perspective, the objective was to determine the most common modeling method practices and review models with aspiring modelers in mind. They strongly encourage including detailed disease progression within the model’s natural history component, to better indicate to #healthcare providers the extra resources needed. Read it here >> https://lnkd.in/eAJWxZm9 #Cancer #Oncology #HEOR #ValueInHealth #EditorsPick #Open Access Thanks to our authors! • Olivia Adair - https://lnkd.in/e-JkC4a6 • Felicity Lamrock - https://lnkd.in/e5Vj-tXt • James F O’Mahony - https://lnkd.in/e_VEbgcN • Mark Lawler - https://lnkd.in/eBxQ_S_G • Ethna McFerran - https://lnkd.in/eQqQ5btH

HEOR Headlines in the News: - “Unlocking Affordability and Access With HEOR” (Value & Outcomes Spotlight) - “Climate Change Is Silently Eroding Workforce Health and Productivity” (Health Affairs Forefront) - “Streamlining Development and Assessment of Biosimilar Medicines” (European Medicines Agency) Visit the HEOR News Desk for curated news stories from a variety of sources. Want these delivered directly to your inbox? Subscribe to the HEOR News Brief here>> https://ow.ly/sWyg50VXrlO #HEOR #climatechange #biosimilars #healthcare #globalhealth Be sure to follow the HEOR Conferences LinkedIn page for updates on all ISPOR events>> https://ow.ly/fIoI50VXrlP

A new report published in the May 2025 issue of Value in Health by the ISPOR Medication Adherence and Persistence Special Interest Group explores the diverse perspectives of key stakeholders on interventions to improve medication adherence. The report titled, “Stakeholders’ Perspectives on Medication Adherence Enhancing Interventions,” reveals that patients, providers, manufacturers, and health technology assessment agencies each prioritize different aspects, such as personalized care, AI-driven tools, health equity, and cost-effectiveness. Read the article here: https://ow.ly/25fb50VVgrj Read the press release here: https://ow.ly/2THI50VVgri #HEOR #MedicationAdherence #HTA #ValueInHealth

Protecting #WholeHealth requires a health ecosystem that is intentionally coordinated where multiple sectors, including healthcare, public health, community agencies, and policymakers, work together. In this commentary, Fountain et al outline 3 tactical areas central to the CDC’s work to break down siloes and integrate #PublicHealth with healthcare: payment, quality measurement, and workforce development. #HEOR #healthcare #ValueInHealth #EditorsPick Read it here >> https://lnkd.in/ehpYj9wz Thank you to our authors! Alison Fountain - https://lnkd.in/e5Gq62a4 Gayane Baziyants - https://lnkd.in/eWq98RAC Aisha Mahmood - https://lnkd.in/ejQHZAVv Abigail Viall - https://lnkd.in/eq7nueT2 Debra Houry Charlene Wong - https://lnkd.in/eX3E3GQt

ISPOR’s very own Chief Science Officer, Laura Pizzi, will be joining an outstanding lineup of industry leaders for a high-impact panel at ACCESS US’25, focusing on the evolving role of health economics & outcomes research (HEOR) in driving market access success. The panel will examine how HEOR can be strategically positioned within increasingly complex organizations to enhance visibility, collaboration, and commercial impact. Topics will include organizational models, internal governance, and best practices for HEOR and Access alignment. Panelists include: - Moderator: Betsy Lahue, CEO, Alkemi - Deb Mitra, Senior Director, Access Strategy Pricing Franchise Lead Immunology and Inflammation, Pfizer - Laura Pizzi, Chief Science Officer, ISPOR - Shuvayu Sen, Vice President V&I OR Oncology, Merck - Jie Zhang, Head, Global Pipeline Market Access, CSL Don't miss this insightful discussion at the intersection of evidence generation and access strategy! Get details here: https://lnkd.in/ecDgZjKz

The ISPOR Women in Health Economics and Outcomes Research Initiative has published a new report titled, “How Well Are Women Represented in Authorship in HEOR? An Analysis of Value in Health: An ISPOR Report” in this month’s issue of Value in Health. This study is aimed to assess how well women are represented in authorship of papers in the field of health economics and outcomes research (HEOR) and whether that representation was affected by the COVID pandemic. Read the article here: https://ow.ly/TZmE50VVg0J Read the press release here https://ow.ly/vQaO50VVg0L #HEOR #WomenInHEOR #ValueInHealth

In this commentary, Nabyonga-Orem et al emphasize that #WholeHealth is feasible but there is need to reconfigure health system management. Noteworthy is the need for political commitment coupled with sustained actions. Sustainable systems that deliver whole health need a unique complement of governance, health workforce, and service delivery models at the local, national, and global levels—including commitment from global partners in funding decisions and implementation approaches. #HEOR #ValueInHealth #EditorsPick Read here >> https://lnkd.in/eSXbyu7v Thanks to our authors! Juliet Nabyonga-Orem https://lnkd.in/exHeeRFZ Kizito Aidam Richard Banda

Did you know ISPOR Student and LMIC Members have free access to the Tufts Center for the Evaluation of Value and Risk in Health (CEVR) CEA Registry? The CEA Registry is a comprehensive database of >10,000 cost-utility analyses on a wide variety of diseases and treatments published from 1976 to the present. Join today! 🔗 https://ow.ly/bUWs50VV8F0 #MembershipMonday #CEARegistry #CEA #LMIC #ISPORstudents